Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 550 of 1467 entries
View as:

Risedronate in Postmenopausal Women With Low Bone Density

Phase: N/A Priority: Normal
NCT ID: NCT00351091 Org: User:
Start: 11/30/02 End: 06/30/03 Due: 06/30/04

Aflibercept and Standard Chemotherapy (R-CHOP) in First Line of Non Hodgkin B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00644124 Org: User:
Start: 03/31/08 End: 10/31/11 Due: 10/31/12

Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties

Phase: N/A Priority: Normal
NCT ID: NCT00805350 Org: User:
Start: 12/31/08 End: 06/30/09 Due: 06/30/10

A Study to Investigate the Pharmacokinetics, Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05976360 Org: User:
Start: 11/02/14 End: 01/17/15 Due: 01/17/16

Interaction Study of Clopidogrel 300/75 mg Given Alone or Concomitantly With Omeprazole 80 mg in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01129375 Org: User:
Start: 02/28/09 End: 05/31/09 Due: 05/31/10

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01630369 Org: User:
Start: 02/29/12 End: 05/31/13 Due: 05/31/14

Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Phase: N/A Priority: Normal
NCT ID: NCT00453570 Org: User:
Start: 03/31/07 End: 01/31/09 Due: 01/31/10

Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02984683 Org: User:
Start: 03/23/17 End: 09/07/18 Due: 09/07/19

Thiocolchicoside Injection and Capsule in Treatment of Acute Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT00917436 Org: User:
Start: 12/31/04 End: 07/31/05 Due: 07/31/06

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02752828 Org: User:
Start: 05/23/16 End: 03/12/18 Due: 03/12/19

The Efficacy, Onset of Effect, and Safety of Alfuzosin Once Daily in the Treatment of Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A Randomized, Placebo-Controlled Trial Using an Acute International Prostate Score

Phase: N/A Priority: Normal
NCT ID: NCT00540891 Org: User:
Start: 02/28/03 End: 10/31/04 Due: 10/31/05

Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)

Phase: N/A Priority: Normal
NCT ID: NCT00249795 Org: User:
Start: 06/30/03 End: 08/31/09 Due: 08/31/10

TREAD-20: Trial of Hyalgan Three Injection-Regimen for the Treatment of Knee Pain Due to Osteoarthritis

Phase: N/A Priority: Normal
NCT ID: NCT00130468 Org: User:
Start: 11/30/04 End: 05/31/06 Due: 05/31/07

Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT02573233 Org: User:
Start: 01/27/16 End: 01/03/18 Due: 01/03/19

Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement

Phase: N/A Priority: Normal
NCT ID: NCT00354939 Org: User:
Start: 10/31/03 End: 03/31/04 Due: 03/31/05

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

Phase: N/A Priority: Normal
NCT ID: NCT07007962 Org: User:
Start: 07/21/25 End: 12/30/28 Due: 12/30/29

Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT00489489 Org: User:
Start: 05/31/07 End: 06/30/09 Due: 06/30/10

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea

Phase: N/A Priority: Normal
NCT ID: NCT03761134 Org: User:
Start: 11/30/18 End: 04/29/20 Due: 04/29/21

A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)

Phase: N/A Priority: Normal
NCT ID: NCT02373202 Org: User:
Start: 02/28/15 End: 11/30/16 Due: 11/30/17

I SAVE - Irbesartan in Mild to Moderate Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00335673 Org: User:
Start: 02/28/06 End: 11/30/06 Due: 11/30/07

E3-Hormone Refractory Prostrate Cancer Taxotere Combination

Phase: N/A Priority: Normal
NCT ID: NCT00498797 Org: User:
Start: 12/31/05 End: 09/30/08 Due: 09/30/09

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (GETGOAL-MONO Japan LTS)

Phase: N/A Priority: Normal
NCT ID: NCT00905255 Org: User:
Start: 05/31/09 End: 01/31/11 Due: 01/31/12

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00718224 Org: User:
Start: 07/31/08 End: 05/31/09 Due: 05/31/10

To Evaluate the Effect of Different Doses of SAR156597 Given to Patients With Idiopathic Pulmonary Fibrosis (IPF)

Phase: N/A Priority: Normal
NCT ID: NCT01529853 Org: User:
Start: 01/31/12 End: 10/31/13 Due: 10/31/14

An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00266747 Org: User:
Start: 12/31/05 End: 01/31/07 Due: 01/31/08